ARCHIVES

Ovarian Suppression Treatment Plus Tamoxifen Can Lower Recurrence Risk

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

NSABP’s Pink Sheet; Fisher’s Control Had A Downside, Review Said

June 24, 1994

Becker, Jako, Epstein Wrangle Over Basic Research, ‘Cancer Establishment’

May 15, 1992

Three New RFAs Announced In Cancer Control

November 3, 1978

In Brief: Healy To Use 1 Percent Transfer Authority For TB Research; Zoon Heads FDA’s CBER

March 20, 1992

75% Of Fed Research Funds Pay Direct Costs, Study Says.

July 28, 2000

Highlights of Dingell Hearing: Statements Of Visco, Testimony By Broder On Fisher, Uterine Cancer Deaths

April 22, 1994